Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolving Role of Anti-Müllerian Hormone Measurements in Clinical Practice.

The journal of applied laboratory medicine·2025
Same author

The 2024 PhD Board-Certified Clinical Chemist Compensation Survey.

The journal of applied laboratory medicine·2025
Same author

Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals.

American journal of clinical pathology·2024
Same author

Bridging the gap: The critical role of laboratory developed tests in clinical toxicology.

Journal of mass spectrometry and advances in the clinical lab·2023
Same author

Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2022
Same author

SARS-CoV-2 Seroprevalence Among First Responders in Northeastern Ohio, 2020.

Public health reports (Washington, D.C. : 1974)·2022
Same journal

Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

American journal of clinical pathology·2026
Same journal

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

American journal of clinical pathology·2026
Same journal

Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

American journal of clinical pathology·2026
Same journal

Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

American journal of clinical pathology·2026
Same journal

Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

American journal of clinical pathology·2026
Same journal

Musculoskeletal pain in medical laboratory personnel: a cross-sectional study.

American journal of clinical pathology·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

19.4K

Pathology consultation on prostate-specific antigen testing.

Jaime H Noguez1, Corinne R Fantz2

  • 1From the Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA. jaime.noguez@emory.edu.

American Journal of Clinical Pathology
|June 14, 2014
PubMed
Summary
This summary is machine-generated.

Prostate-specific antigen (PSA) testing effectively detects prostate diseases but often leads to overdiagnosis and overtreatment due to limitations in distinguishing cancer types. Discussing benefits and harms with a healthcare provider is crucial for informed screening decisions.

Keywords:
Prostate cancerProstate-specific antigenScreening

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.5K
Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

2.5K

Related Experiment Videos

Last Updated: Apr 28, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

19.4K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.5K
Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

2.5K

Area of Science:

  • Urology
  • Oncology
  • Biomarker Discovery

Background:

  • Prostate-specific antigen (PSA) is a widely used biomarker for prostate cancer screening.
  • Controversy exists regarding the clinical utility and interpretation of PSA test results.

Observation:

  • PSA is sensitive for detecting prostate conditions but struggles to differentiate between cancerous and non-cancerous states.
  • The test also has limitations in distinguishing aggressive from indolent prostate cancers.

Findings:

  • PSA screening has led to significant overdiagnosis and subsequent overtreatment of prostate cancer.
  • Despite limitations, the analytical methodology for total PSA testing is reliable and cost-effective.

Implications:

  • Patients need comprehensive counseling on the potential benefits and harms of PSA screening.
  • Shared decision-making between patients and providers is essential for appropriate prostate cancer screening strategies.